Gleostine is an alkylating drug indicated
for the treatment of patients with:

• Brain tumors, primary and metastatic,
  following appropriate surgical
  and/or radiotherapeutic procedures.


• Hodgkin’s lymphoma in combination
  with other chemotherapies, following
  disease progression with initial chemotherapy.

A Statement Regarding Media Coverage of Gleostine® (lomustine )